The Enzyme Revolution: How Lactase Is Reshaping Lactose Intolerance Treatment and the Dairy Industry

Lactose intolerance treatment has come a long way from the days when sufferers were simply advised to avoid milk and dairy products altogether. What was once a condition managed largely through dietary restriction is now being addressed with growing sophistication through enzyme supplementation, lactase-enriched foods, purpose-engineered dairy products, and next-generation dietary innovations that allow millions of people worldwide to enjoy dairy without discomfort. At the center of this transformation is lactase, the naturally occurring digestive enzyme whose industrial production, refinement, and commercial application is now fueling one of the food science sector's most dynamic growth stories. And the Lactase Market is expanding rapidly to meet a global need that cuts across cultures, geographies, and age groups.

Understanding the Scale of the Challenge

Lactose intolerance is far more prevalent than many people realize. According to the National Library of Medicine, lactose intolerance is a prevalent condition among adults, with approximately 30 million American adults experiencing some level of lactose intolerance by the age of 20. Globally, the condition is even more widespread across populations in Asia, Africa, and Latin America, where genetic predisposition to reduced lactase production in adulthood is significantly higher. The condition arises when the body produces insufficient levels of lactase the enzyme responsible for breaking down lactose, the naturally occurring sugar found in milk and dairy into simpler, more easily absorbed sugars. Without adequate lactase, consuming dairy triggers a range of uncomfortable symptoms including bloating, gas, nausea, stomach pain, and diarrhea.

This widespread digestive challenge has created enormous commercial momentum. The global lactase market was valued at USD 238.88 million in 2024 and is expected to grow at a CAGR of 5.70% from 2025 to 2034, with market growth fueled by rising lactose intolerance awareness and demand for dairy-free products. By 2034, the sector is projected to reach USD 414.27 million a robust trajectory that reflects how decisively the food, pharmaceutical, and nutraceutical industries are responding to this unmet consumer need.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/lactase-market

Lactase as the Core Treatment Solution

The most direct and effective approach to managing lactose intolerance centers on lactase supplementation and lactase-enhanced food formulations. The lactase market is experiencing significant growth driven by the growing prevalence of lactose intolerance among individuals, with the rising awareness and demand for lactase products which aid in the digestion of lactose driving lactase market revenue.

Manufacturers are responding with increasingly sophisticated delivery mechanisms. The launch of innovative delivery methods like strength caplets and fast-acting chewables to alleviate lactose digestion issues such as gas, bloating, nausea, stomach pain, and diarrhea drives the market expansion. These over-the-counter solutions give consumers flexibility and control the ability to enjoy dairy in social settings or at restaurants without planning dietary avoidance in advance. Simultaneously, the food and beverage industry is incorporating lactase directly into products at the manufacturing stage. In April 2024, Prairie Farms Dairy introduced four new lactose-free dairy products, including cottage cheese, milk, sour cream, and others, with plans to expand distribution across the United States.

Innovation in lactase formulations is also opening new frontiers. In April 2021, IFF introduced Nurica in the United States, a dairy enzyme that utilizes the lactose found in milk to produce galacto-oligosaccharides (GOS) fibers, resulting in decreased levels of lactose and sugar. Such dual-benefit formulations simultaneously reducing lactose while adding prebiotic fiber illustrate how far lactase technology has progressed beyond simple enzyme replacement.

The Biotechnology Engine Behind Growth

The bacteria segment is anticipated to grow with the highest CAGR in the market due to advancements in biotechnology and enzymology, with bacteria-derived lactase enzymes such as Lactobacillus acidophilus, Enterococcus faecalis, and Bifidobacterium longum being scalable, cost-effective, and environmentally sustainable. These microbial sources represent the leading edge of lactase production science, offering manufacturers consistent enzyme activity across diverse pH and temperature conditions essential for reliable performance in both industrial food processing and consumer supplement applications.

Processing efficiency is also improving rapidly. In June 2023, DSM-Firmenich launched Maxilact Next, a highly efficient lactase enzyme designed to optimize lactose-free dairy production, which reduced hydrolysis time by 25%, enhancing capacity, raw material efficiency, and taste without compromising quality. These advances directly reduce production costs and improve product quality making lactose-free options more accessible and more commercially appealing simultaneously.

Regional Dynamics and Future Outlook

The North America region dominated the lactase market owing to the significant number of lactose-intolerant individuals in the region, with rising health consciousness among consumers leading to substantial developments with increased nutritional composition in supplements, as well as food and beverage items. The Asia-Pacific region, however, represents the sector's most exciting growth frontier. The Asia-Pacific lactase market is expected to grow at the fastest CAGR, as the lactase enzyme has gained economic significance owing to the rising demand from the food and beverage industry and rapid industrialization particularly in China, India, and Vietnam.

Strategic investment at the corporate level is accelerating alongside this regional growth. In December 2023, Kerry Group PLC acquired a segment of the lactase enzyme business from Novozymes and Chr. Hansen, including NOLA Products, aimed at expanding Kerry's enzyme technology for lactose-free dairy. Meanwhile, in 2025, Valio opened a new lactase enzyme R&D center in Helsinki dedicated to advancing lactase technology and accelerating innovation in lactose-free dairy products.

As consumer health awareness grows and the global demand for inclusive, digestive-friendly food products intensifies, lactase is emerging as one of the most consequential enzymes in the modern food system turning a widespread digestive condition into a solved problem, one dairy product at a time.

More Trending Latest Reports By Polaris Market Research:

Soda Maker Market

Drone Batteries Market

Model Based Enterprise Market

Extended Stay Hotel Market

Drone Batteries Market

Operational Technology Market

Regenerative Medicine Market

Biofertilizers Market

Oncology Based Molecular Diagnostics Market